CDK4 and neutropenia: Except for neutropenia, we focused on severe adverse events (toxicity grade 3–4), toxicities that led to the suspension of radiotherapy or CDK4/6i, and toxicities leading to dose reduction or treatment discontinuation (either RT or CDK4/6i).